RWE-based Treatment Patterns and Outcomes in CIDP

Conditions:   Chronic Inflammatory Demyelinating Polyneuropathy;   Guillain-Barre Syndrome;   Hereditary Amyloidosis Intervention:   Other: No intervention. Retrospective observation only. Sponsors:   RwHealth;   Alnylam Pharmaceuticals;   Northern Care Alliance NHS Foundation Trust Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials